The Health Effects of Cannabis – Informed Opinions

Input canvass opinions and any public or bar place on cannabis and there will be a different view for every individual. Some remarks will be well-informed from sources that are respectable while some are going to be only formed upon no foundation in any way. To be sure, study and decisions based on the research are difficult given the history of illegality. Nonetheless, is a groundswell of opinion that cannabis is good and must be legalized. Most States in America and Australia have taken the path. Other nations are either following suit or considering choices. So what is the position? Is it?

The National Academy of Sciences released a 487-page report that this season (NAP Report) on the present state of evidence for the topic matter. Government grants affirmed the committee, an eminent collection of 16 professors’ work. 15 reviewers and some 700 publications encouraged them. The report is seen as state of the art on medical as well as use. This article draws heavily on this resource.

The term cannabis is used loosely here to signify cannabis and marijuana, the latter being mined from another portion of the plant. More than 100 chemical compounds are present each potentially offering distinct benefits or risk. Safety Culture Works


A man who can be”benign” on smoking cannabis may experience a euphoric state where time is irrelevant, music and colors take on a greater significance and the person might obtain the”nibblies”, wanting to eat fatty and sweet foods. This is frequently related to motor skills and perception. When high blood clots have been attained, paranoid thoughts, hallucinations and panic attacks can describe his”trip”.


From the vernacular, cannabis is often characterized as”good shit” and”bad shit”, alluding to widespread contamination clinic. The contaminants may come from soil standard (eg pesticides & heavy metals) or added afterward. Particles of beads of glass augment the weight sold.


A random selection of curative effects appears here in the context of the signs standing. A few of the effects will be revealed as beneficial, while some carry danger. Some effects are barely distinguished from the placebos of the research.

  • Cannabis at the treatment of epilepsy is inconclusive due to inadequate evidence.
  • Nausea and vomiting caused by chemotherapy may be ameliorated by oral cannabis.
  • A decline in the severity of pain in patients with chronic pain is a probable outcome for the usage of cannabis.
  • Spasticity in Multiple Sclerosis (MS) patients were reported as developments in symptoms.
  • The boost in appetite and decrease in weight loss in HIV/ADS patients has been shown in limited signs.
  • Based on restricted signs, cannabis is unsuccessful in the treatment of glaucoma.
  • On the basis of limited evidence, cannabis is effective in treating Tourette syndrome.
  • The celiac disease was aided by cannabis in one reported trial.
  • Restricted statistical evidence points to enhance results for traumatic brain injury.
  • There is inadequate evidence to claim that cannabis can help Parkinson’s disease.
  • Limited signs dashed hopes that cannabis could help improve the symptoms of dementia victims.
  • Limited statistical evidence can be found to support a connection between smoking cannabis and heart attack.
  • On the basis of limited evidence, cannabis is ineffective to treat depression
  • The evidence for a reduced risk of metabolic issues (diabetes ) is limited and statistical.
  • Social anxiety disorders can be helped by cannabis, although the evidence is limited. Asthma and cannabis usage is not well supported by the evidence either for or against.
  • The post-traumatic disorder has been helped by cannabis in a single reported trial.
  • An end which cannabis can help schizophrenia sufferers can’t be supported or refuted on the grounds of their restricted nature of the signs.
  • There is moderate evidence that better short-term sleep results for disturbed sleep folks.
  • Alcoholism and smoking cannabis are connected with the decreased birth weight of the infant.
  • The evidence for stroke caused by cannabis use is restricted and statistical.
  • Addiction to cannabis and gateway problems are complex, taking into consideration many factors that are beyond the scope of this report. These issues are discussed in the NAP report.


The NAP report highlights the following findings on the issue of cancer:

  • The evidence indicates that smoking cannabis doesn’t raise the risk for specific cancers (i.e., lung, head and throat ) in adults.
  • There is little evidence that cannabis use is associated with one subtype of testicular cancer.
  • There is minimal evidence that parental cannabis use during pregnancy is related to greater cancer risk in offspring.


The NAP report highlights the following findings on the issue of respiratory ailments:


The NAP report highlights the following findings on the issue of the human immune system:

  • There exists a paucity of information on the consequences of cannabis or cannabinoid-based therapeutics on the individual immune system.
  • There is insufficient data to draw philosophical conclusions regarding the effects of cannabis smoke or cannabinoids on immune tolerance.
  • There is limited evidence to suggest that regular exposure to cannabis smoke could have anti-inflammatory activity.
  • There’s insufficient evidence to support or refute a statistical association between cannabis or cannabinoid usage and adverse impacts on immune status in people with HIV.


The NAP report highlights the following findings on the Dilemma of the increased risk of death or injury:

  • Cannabis use before driving increases the risk of being involved in a motor vehicle collision.
  • In states where cannabis use is lawful, there is an elevated risk of unintentional cannabis overdose injuries in kids.
  • It is unclear whether and how cannabis use is related to all-cause mortality or having an occupational injury.


The NAP report highlights the following findings on the issue of cognitive performance and mental health:

  • Present cannabis use impairs the performance in the cognitive domain of learning, memory, and focus. Recent use might be described as cannabis usage.
  • A limited number of studies suggest there are impairments in the cognitive domain of learning, memory, and focus in individuals who have stopped smoking cannabis.
  • Cannabis use during adolescence is related to impairments in following academic achievement and schooling, employment and income, and social relationships and social roles.
  • Cannabis use is likely to boost the risk of developing schizophrenia and other psychoses; the greater the usage, the larger the risk.
  • In people with schizophrenia and other psychoses, a history of cannabis use could be linked to improved performance on learning and memory activities.
  • Cannabis use does not seem to increase the probability of developing depression, anxiety, and posttraumatic stress disorder.
  • For individuals diagnosed with bipolar disorders, near-daily cannabis use may be linked to greater symptoms of bipolar disorder compared to nonusers.
  • Heavy cannabis users are more inclined to report thoughts of suicide than are nonusers.
  • Regular cannabis use is very likely to boost the potential of developing a social anxiety disorder.

It has to be fairly clear from the foregoing that cannabis isn’t the magic bullet for all health problems which some good-intentioned but ill-advised advocates of cannabis could have us think. Yet hope is offered by the product. Solid research can help to clarify the issues. The NAP report is a solid step in the ideal direction. Unfortunately, there are many obstacles to exploring this amazing drug. In time the benefits and risks will be fully understood. Confidence in the product will increase and many of the barriers, academic and social, will fall by the wayside.